The Dcaf1 Knockout RAW 264.7 Polyclonal Cells are a genetically engineered mouse macrophage population generated by CRISPR/Cas9-mediated disruption of the Dcaf1 gene. This polyclonal knockout cell pool provides a heterogeneous collection of edited cells with loss-of-function mutations in Dcaf1, enabling the study of DCAF1-dependent processes without the limitations of a single clonal isolate.
RAW 264.7 cells are an extensively characterized murine macrophage line derived from BALB/c mice, widely used as a model for monocyte/macrophage biology. These cells exhibit robust phagocytic activity, cytokine secretion, and antigen presentation capabilities, recapitulating key innate immune functions. Their stable in vitro growth and well-documented signaling responses make them a versatile platform for studying immune regulation, host-pathogen interactions, and inflammatory signaling pathways.
DCAF1 (DDB1- and CUL4-associated factor 1) serves as a substrate recognition subunit within the CRL4 (Cullin4-RING E3 ubiquitin ligase) complex. As an adaptor protein, DCAF1 bridges CUL4A/B and DDB1 to target specific substrates for polyubiquitination and subsequent proteasomal degradation. This activity is tightly regulated by the neddylation cycle and the exchange factor CAND1. DCAF1 is known to interact with viral proteins such as HIV-1 Vpr and host restriction factors like SAMHD1, mediating their ubiquitination. Endogenous substrates include the DNA replication licensing factor CDT1, the cyclin-dependent kinase inhibitor p21, and core histones, implicating DCAF1 in cell cycle control, DNA damage response, and chromatin dynamics. Through these interactions, DCAF1 modulates proteostasis and signal transduction pathways critical for cellular homeostasis and immune function.
In RAW 264.7 macrophages, DCAF1 plays a pivotal role in balancing immune activation and cell proliferation. CRISPR/Cas9-mediated disruption of Dcaf1 in this macrophage line allows researchers to dissect the contribution of CRL4 E3 ligase activity to innate immune responses, including cytokine production, phagocytosis, and antigen presentation. The polyclonal knockout pool circumvents clonal artifacts and provides a more physiologically relevant representation of gene disruption effects, reflecting the stochastic nature of CRISPR editing. This model is particularly valuable for investigating how DCAF1-dependent degradation of signaling intermediates influences macrophage polarization and effector functions in response to microbial stimuli or inflammatory cues.
Applications of this polyclonal knockout model span diverse areas of biomedical research. Scientists can employ these cells for ubiquitin ligase substrate identification through comparative proteomics, study proteostasis mechanisms via pulse-chase degradation assays, or investigate the role of CRL4-DCAF1 in macrophage immune signaling using flow cytometry and cytokine profiling. The cells enable co-immunoprecipitation experiments to map CRL4 complex assembly and substrate interactions, and provide a system for evaluating HIV-host interactions mediated by Vpr and SAMHD1. Functional macrophage assays such as phagocytosis and antigen presentation analyses can be conducted to assess innate immune competence. These cells thus serve as a reliable tool for elucidating DCAF1-mediated ubiquitination pathways and their implications in cancer, immune disorders, and viral infection. For further information, please contact Ascent Research.
